(Q45152653)

10 December 2017

1 reference

title

Cyclosporine microemulsion formulation (Neoral) in transplantation: pharmacokinetic/pharmacodynamic relationships (English)

1 reference

10 December 2017

1 reference

1 reference

1 reference

Mueller EA

1

1 reference

10 December 2017

Niese D

series ordinal

2

1 reference

10 December 2017

Mellein B

series ordinal

3

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 August 1998

1 reference

Transplantation Proceedings

10 December 2017

published in

1 reference

10 December 2017

volume

30

1 reference

10 December 2017

issue

5

1 reference

10 December 2017

page(s)

1694-1696

1 reference

Low intrapatient variability of blood cyclosporine levels is correlated with excellent graft survival

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Effect of cyclosporine intervariability on the long-term outcome of renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Blood cyclosporin concentrations and the short-term risk of lung rejection following heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Neoral vs Sandimmun: interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients. The U. K. Neoral Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients--a concentration-controlled comparison with the commercial formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Improved absorption of cyclosporin A from a new microemulsion formulation: implications for dosage and monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Immunosuppression (Neoral vs Sandimmune) in pediatric kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

A microemulsion of cyclosporine without intravenous cyclosporine in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Neoral compared to Sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Comparison of efficacy, safety, and tolerability of Neoral vs Sandimmun in de novo renal transplant patients over 24 months' treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary renal allograft recipients: a report of the Neoral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900396-0

7 January 2021

10.1016/S0041-1345(98)00396-0

Identifiers

DOI

1 reference

10 December 2017

1 reference